Auxilium planning $200M note deal

Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) said it plans to raise $200 million through the sale of convertible senior notes due 2018. Goldman Sachs; JPMorgan; Cowen; and RBC Capital Markets are underwriters. Auxilium, which made the announcement after market close, was up $0.20 to $18.74 on Wednesday. ...